Former Medtronic China Executive Appointed President of Danaher's Diagnostics Platform in China

On January 13, Danaher Group announced important personnel changes in the China Diagnostic Platform: Chen Xiaosui (Rosa) will step down as President of the China Diagnostic Platform; Yu Jing,Former Vice President of Medtronic and General Manager of China Orthopedics and Neurosurgery Business Will Assume the Position.

Rosa Chen

Yu Jing

Chen Xiaosui joined Danaher in September 2021. Over the past four and a half years, she has led her team through a critical phase of intense policy adjustments and increasing competition in China's in vitro diagnostics (IVD) industry, with a clear and rapid career advancement path:

• In February 2022, promoted to Vice President and General Manager of Beckman Coulter Diagnostics China;

• In January 2023, responsibilities expanded to include Dx manufacturing, digitalization, and key account management, among other areas;

• In January 2024, promoted to President of Danaher China Diagnostic Platform, overseeing the management of Beckman Coulter, Radiometer, Leica and other brand businesses, and entering the core management team in China.

Danaher fully recognized her contributions in the internal evaluation: Under multiple challenges such as Volume-Based Procurement (VBP), she led her team to achieve counter-trend growth and market share increase. By strengthening cross-business collaboration, promoting localized innovation, and continuously optimizing operations and customer experience, she made significant progress.

The successor, Yu Jing, has rich industry experience.Public information shows that she has worked at GE Healthcare for more than 20 years., and then served as the General Manager of Medtronic China Orthopedics and Neurosurgery business in 2019.During her tenure, she promoted the digital and intelligent transformation of the business, led the development of the AIBLE Digital Orthopedics and Neurosurgery Integrated Solution, and participated in the construction of the Changzhou Science Park Innovation Incubation Center. In November 2025, Medtronic announced her departure due to personal development reasons.